{"filing":{"accession_number":"0001380106-26-000097","cik":"0001380106","ticker":"RPID","company_name":"RAPID MICRO BIOSYSTEMS, INC.","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-07","primary_document":"rpid-20260807.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000097/rpid-20260807.htm"},"events":[{"id":26175,"run_id":23773,"accession_number":"0001380106-26-000097","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release disclosing Rapid Micro Biosystems' second quarter 2026 financial results. The Item 2.02 filing explicitly states the company \"issued a press release announcing its financial results for its second quarter ended June 30, 2026,\" with the press release attached as Exhibit 99.1. The disclosure includes detailed quarterly revenue ($8.1M, up 11% YoY), gross margin (15%, a record), net loss ($12.9M), and full-year 2026 guidance reaffirmation—all hallmarks of a standard quarterly earnings announcement.","company_name":"RAPID MICRO BIOSYSTEMS, INC.","ticker":"RPID","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":27204,"accession_number":"0001380106-26-000097","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Rapid Micro Biosystems' second quarter 2026 financial results. The Item 2.02 filing explicitly states the company \"issued a press release announcing its financial results for its second quarter ended June 30, 2026,\" with the press release attached as Exhibit 99.1. The disclosure includes detailed quarterly revenue ($8.1M, up 11% YoY), gross margin (15%, a record), net loss ($12.9M), and full-year 2026 guidance reaffirmation—all hallmarks of a standard quarterly earnings announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T03:11:35.962717+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27204,"accession_number":"0001380106-26-000097","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Rapid Micro Biosystems' second quarter 2026 financial results. The Item 2.02 filing explicitly states the company \"issued a press release announcing its financial results for its second quarter ended June 30, 2026,\" with the press release attached as Exhibit 99.1. The disclosure includes detailed quarterly revenue ($8.1M, up 11% YoY), gross margin (15%, a record), net loss ($12.9M), and full-year 2026 guidance reaffirmation—all hallmarks of a standard quarterly earnings announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T03:11:35.962717+00:00","company_name":"RAPID MICRO BIOSYSTEMS, INC.","ticker":"RPID","filing_date":"2026-08-07"}]}